Compare BZFD & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZFD | CCEL |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | BZFD | CCEL |
|---|---|---|
| Price | $0.92 | $3.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 395.9K | 16.0K |
| Earning Date | 03-12-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 11.73% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $184,927,000.00 | $31,747,500.00 |
| Revenue This Year | $0.51 | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $325.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.83 | $3.10 |
| 52 Week High | $2.72 | $8.79 |
| Indicator | BZFD | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 40.69 |
| Support Level | $0.89 | $3.33 |
| Resistance Level | $1.06 | $3.64 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 41.04 | 29.81 |
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.